Correcting for Antibody Waning in Cumulative Incidence Estimation from Sequential Serosurveys.

Kadelka, Sarah; Bouman, Judith A; Ashcroft, Peter; Regoes, Roland R (2023). Correcting for Antibody Waning in Cumulative Incidence Estimation from Sequential Serosurveys. (In Press). American journal of epidemiology Oxford University Press 10.1093/aje/kwad226

Preview

Text kwad226.pdf - Accepted Version Available under License Creative Commons: Attribution (CC-BY). Download (821kB) | Preview

Serosurveys are a widely used tool to estimate the cumulative incidence, i.e. the fraction of a population that have been infected by a given pathogen. These surveys rely on serological assays that measure the level of pathogen-specific antibodies. Because antibody levels are waning, the fraction of previously infected individuals that have sero-reverted increases with time past infection. To avoid underestimating the true cumulative incidence, it is therefore essential to correct for waning antibody levels. We present an empirically-supported approach for sero-reversion correction in cumulative incidence estimation when sequential serosurveys are conducted in the context of a newly emerging infectious disease. The correction is based on the observed dynamics of antibody titers in sero-positive cases and validated using several in silico test scenarios. Furthermore, through this approach we revise a previous cumulative incidence estimate, which relies on the assumption of an exponentially-declining probability of sero-reversion over time, of SARS-CoV-2 of 76% in Manaus, Brazil, by October 2020 to 47.6% (43.5% - 53.5%). This estimate has implications e.g. for the proximity to herd immunity in Manaus in late 2020.

Interest & Impact

Downloads

1 since deposited on 29 Nov 2023
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item